Business Description
China National Medicines Corp Ltd
NAICS : 325412
ISIN : CNE000001D56
Share Class Description:
SHSE:600511: Class ACompare
Compare
Traded in other countries / regions
600511.China IPO Date
2002-11-27Description
China National Medicines Corp Ltd focuses on producing special drugs and high-end prescription drugs. Its main goal is to provide customers with professional medical services. The Company has one main reportable segment, the Commercial segment, which consists of the operating segment of pharmaceutical sales. Its other reportable segments consist of pharmaceutical production and logistics segments The company is also engaged in proprietary Chinese medicines, Chinese medicine decoction pieces, Chinese medicinal materials, chemical preparations, chemical raw materials, antibiotics and biochemical drugs.
Financial Strength
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 17.03 | |||||
Equity-to-Asset | 0.49 | |||||
Debt-to-Equity | 0.03 | |||||
Debt-to-EBITDA | 0.18 | |||||
Interest Coverage | 97.24 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 3.87 | |||||
Beneish M-Score | -2.33 | |||||
WACC vs ROIC |
Growth Rank
8/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.2 | |||||
3-Year EBITDA Growth Rate | 13.8 | |||||
3-Year EPS without NRI Growth Rate | 17.1 | |||||
3-Year FCF Growth Rate | 27.9 | |||||
3-Year Book Growth Rate | 11.3 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 68.58 | |||||
9-Day RSI | 61.8 | |||||
14-Day RSI | 55.54 | |||||
6-1 Month Momentum % | 1.92 | |||||
12-1 Month Momentum % | -6.57 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.08 | |||||
Quick Ratio | 1.77 | |||||
Cash Ratio | 0.68 | |||||
Days Inventory | 32.17 | |||||
Days Sales Outstanding | 53.67 | |||||
Days Payable | 84.62 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 2.67 | |||||
Dividend Payout Ratio | 0.26 | |||||
3-Year Dividend Growth Rate | 7 | |||||
Forward Dividend Yield % | 2.67 | |||||
5-Year Yield-on-Cost % | 4.94 | |||||
Shareholder Yield % | 2.91 |
Profitability Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 7.87 | |||||
Operating Margin % | 4.91 | |||||
Net Margin % | 4.33 | |||||
FCF Margin % | 3.97 | |||||
ROE % | 14.35 | |||||
ROA % | 6.94 | |||||
ROIC % | 20.62 | |||||
ROC (Joel Greenblatt) % | 317.38 | |||||
ROCE % | 16.63 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 11.11 | |||||
PE Ratio without NRI | 10.71 | |||||
Shiller PE Ratio | 15.81 | |||||
Price-to-Owner-Earnings | 11.52 | |||||
PEG Ratio | 1.6 | |||||
PS Ratio | 0.47 | |||||
PB Ratio | 1.5 | |||||
Price-to-Tangible-Book | 1.55 | |||||
Price-to-Free-Cash-Flow | 12.15 | |||||
Price-to-Operating-Cash-Flow | 11.35 | |||||
EV-to-EBIT | 5.18 | |||||
EV-to-EBITDA | 5.18 | |||||
EV-to-Revenue | 0.3 | |||||
EV-to-FCF | 7.53 | |||||
Price-to-Projected-FCF | 0.87 | |||||
Price-to-DCF (Earnings Based) | 0.55 | |||||
Price-to-DCF (FCF Based) | 0.39 | |||||
Price-to-Median-PS-Value | 0.82 | |||||
Price-to-Peter-Lynch-Fair-Value | 1.78 | |||||
Price-to-Graham-Number | 0.86 | |||||
Price-to-Net-Current-Asset-Value | 2.05 | |||||
Earnings Yield (Greenblatt) % | 19.31 | |||||
FCF Yield % | 8.25 | |||||
Forward Rate of Return (Yacktman) % | 12.32 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
China National Medicines Corp Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil ¥) | 50,591.887 | ||
EPS (TTM) (Â¥) | 2.904 | ||
Beta | 0.45 | ||
Volatility % | 25.43 | ||
14-Day RSI | 55.54 | ||
14-Day ATR (Â¥) | 0.738319 | ||
20-Day SMA (Â¥) | 31.1955 | ||
12-1 Month Momentum % | -6.57 | ||
52-Week Range (Â¥) | 26.58 - 37.8 | ||
Shares Outstanding (Mil) | 754.5 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 4 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
China National Medicines Corp Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
China National Medicines Corp Ltd Stock Events
Event | Date | Price(Â¥) | ||
---|---|---|---|---|
No Event Data |
China National Medicines Corp Ltd Frequently Asked Questions
What is China National Medicines Corp Ltd(SHSE:600511)'s stock price today?
The current price of SHSE:600511 is ¥32.25. The 52 week high of SHSE:600511 is ¥37.80 and 52 week low is ¥26.58.
When is next earnings date of China National Medicines Corp Ltd(SHSE:600511)?
The next earnings date of China National Medicines Corp Ltd(SHSE:600511) is .
Does China National Medicines Corp Ltd(SHSE:600511) pay dividends? If so, how much?
The Dividend Yield %  of China National Medicines Corp Ltd(SHSE:600511) is 2.67% (As of Today), Highest Dividend Payout Ratio of China National Medicines Corp Ltd(SHSE:600511) was 0.37. The lowest was 0.09. And the median was 0.26. The  Forward Dividend Yield % of China National Medicines Corp Ltd(SHSE:600511) is 2.67%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |